glycopeptide

(redirected from Glycopeptide antibiotic)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

glycopeptide

[‚glī·kō′pep‚tīd]
(biochemistry)
References in periodicals archive ?
Oritavancin, Targanta's lead product candidate, is a once-daily, semi- synthetic glycopeptide antibiotic with rapid bactericidal activity against all studied clinically relevant serious gram-positive pathogens, including multi- resistant strains.
Oritavancin, Targanta's lead product candidate, is a once-daily, semi-synthetic glycopeptide antibiotic with rapid bactericidal activity against all clinically relevant serious gram-positive infections, including multi-resistant strains.
These include the clinically important glycopeptide antibiotic vancomycin, which is among several popular drugs that are meeting increased bacterial resistance.
The Company currently plans to investigate regulatory strategies for other product candidates including SDP-015, a novel intravenous formulation of an approved oral antibiotic in the macrolide family known as clarithromycin; SDP-016, a novel formulation of vancomycin, a parenteral glycopeptide antibiotic, which is intended to reduce phlebitis associated with IV-delivery of the drug, and; SDP-011, an intranasal/topical antiviral gel intended as a broad spectrum agent for cold and flu and other viral indications as an over- the-counter (OTC) product.
Oritavancin is a semi-synthetic glycopeptide antibiotic with bactericidal activity against clinically relevant serious Gram-positive infections, including multi-resistant strains.
Nasdaq: MICU; Nuovo Mercato: MICU) today announced the presentation of Phase II data demonstrating superior efficacy of dalbavancin, the company's next-generation injectable glycopeptide antibiotic, compared to vancomycin, the current standard of care for the treatment of catheter-related bloodstream infections (CR-BSI).